Chicago Partners Investment Group LLC Nkarta, Inc. Transaction History

Chicago Partners Investment Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$5.14 - $14.35 $57,125 - $159,485	11,114 New	11,114 $66,000
Q1 2022 May 20, 2022	SELL	$8.66 - $14.99 $95,086 - $164,590	-10,980 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$12.79 - $26.88 $140,434 - $295,142	10,980 New	10,980 $110,000
Q3 2021 Nov 12, 2021	SELL	$26.67 - $38.76 $264,993 - $385,119	-9,936 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$23.94 - $36.68 $54,942 - $84,180	-2,295 Reduced 18.76%	9,936 $308,000
Q1 2021 Apr 28, 2021	BUY	$31.33 - $59.61 $201,545 - $383,471	6,433 Added 110.95%	12,231 $409,000
Q4 2020 Jan 27, 2021	BUY	$27.03 - $75.62 $156,719 - $438,444	5,798 New	5,798 $288,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.